Vanguard Group Inc Foghorn Therapeutics Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,749,660 shares of FHTX stock, worth $9.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,749,660

Previous 1,731,979 1.02%

Holding current value

$9.41 Million

Previous $16.1 Million 48.78%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$4.61 - $9.35 $81,509 - $165,317	17,681 Added 1.02%	1,749,660 $8.26 Million
Q3 2024 Nov 13, 2024	BUY	$4.8 - $9.99 $3.23 Million - $6.72 Million	672,494 Added 63.47%	1,731,979 $16.1 Million
Q2 2024 Aug 13, 2024	SELL	$5.05 - $8.0 $217,190 - $344,064	-43,008 Reduced 3.9%	1,059,485 $6.09 Million
Q1 2024 May 10, 2024	BUY	$2.82 - $7.94 $218,211 - $614,397	77,380 Added 7.55%	1,102,493 $7.4 Million
Q4 2023 Feb 14, 2024	BUY	$2.94 - $6.76 $18,915 - $43,493	6,434 Added 0.63%	1,025,113 $6.61 Million
Q3 2023 Nov 14, 2023	BUY	$5.0 - $9.87 $18,710 - $36,933	3,742 Added 0.37%	1,018,679 $5.09 Million
Q2 2023 Aug 14, 2023	SELL	$5.37 - $8.84 $37,740 - $62,127	-7,028 Reduced 0.69%	1,014,937 $7.15 Million
Q1 2023 May 15, 2023	BUY	$4.66 - $8.99 $18,998 - $36,652	4,077 Added 0.4%	1,021,965 $6.34 Million
Q4 2022 Feb 10, 2023	BUY	$5.44 - $9.46 $27,015 - $46,978	4,966 Added 0.49%	1,017,888 $6.49 Million
Q3 2022 Nov 14, 2022	BUY	$7.52 - $18.01 $40,104 - $96,047	5,333 Added 0.53%	1,012,922 $8.69 Million
Q2 2022 Aug 12, 2022	BUY	$8.48 - $16.84 $1.25 Million - $2.47 Million	146,819 Added 17.06%	1,007,589 $13.7 Million
Q1 2022 May 13, 2022	BUY	$8.87 - $22.1 $142,620 - $355,345	16,079 Added 1.9%	860,770 $13.1 Million
Q4 2021 Feb 14, 2022	BUY	$10.79 - $22.87 $51,511 - $109,181	4,774 Added 0.57%	844,691 $19.3 Million
Q3 2021 Nov 12, 2021	BUY	$8.33 - $15.02 $1.3 Million - $2.35 Million	156,139 Added 22.83%	839,917 $11.7 Million
Q2 2021 Aug 13, 2021	BUY	$9.32 - $13.26 $6.37 Million - $9.07 Million	683,778 New	683,778 $7.3 Million

Others Institutions Holding FHTX

# of Institutions

Shares Held

36.3M

Call Options Held

100

Put Options Held

View Full List

About Foghorn Therapeutics Inc.

Ticker FHTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,637,400
Market Cap $224M
Description
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...

More about FHTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Foghorn Therapeutics Inc. Transaction History